66
Participants
Start Date
May 31, 2024
Primary Completion Date
October 31, 2025
Study Completion Date
October 31, 2025
Tezepelumab
Tezepelumab subcutaneous injection
Placebo
Placebo subcutaneous injection
Aberdeen Royal Infirmary - NHS Grampian, Aberdeen
University Hospitals Birmingham NHS Foundation Trust, Birmingham
Cambridge University Hospitals NHS Foundation Trust, Cambridge
University Hospitals of Leicester NHS Trust, Leicester
Liverpool University Hospitals NHS Foundation Trust, Liverpool
Barts Health NHS Trust, London
Royal Free London NHS Trust, London
Guy's Hospital - Guy's and St Thomas' NHS Foundation Trust, London
Royal Brompton Hospital - Guy's and St Thomas' NHS Foundation Trust, London
Imperial College Healthcare NHS Trust, London
Manchester University NHS Foundation Trust, Manchester
Nottingham University Hospitals NHS Foundation Trust, Nottingham
University Hospital Southampton NHS Foundation Trust, Southampton
Collaborators (1)
AstraZeneca
INDUSTRY
Imperial College London
OTHER